Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
暂无分享，去创建一个
C. Straka | W. Berdel | A. Heinecke | R. Fenk | T. Südhoff | G. Innig | J. Kienast | H. Ostermann | M. Kropff | M. Mitterer | N. Lang | G. Bisping | Nicole Dominé | M. Hentrich | O. Koch